Cite
MLA Citation
MR Mirza et al.. “Long-term safety assessment of niraparib in patients with recurrent ovarian cancer: results from the ENGOT-OV16/NOVA trial.” International journal of gynecological cancer, vol. 29, n.d., pp. A15–A16. http://access.bl.uk/ark:/81055/vdc_100144728809.0x00001b